The evolution of the cancer formulary review in Canada: Can centralization improve the use of economic evaluation?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The evolution of the cancer formulary review in Canada: Can centralization improve the use of economic evaluation?

Published:2016-07-29 Issue:2 Volume:32 Page:e232-e260
ISSN:0749-6753
Container-title:The International Journal of Health Planning and Management
language:en
Short-container-title:Int J Health Plann Mgmt

Author:

Wranik W. Dominika¹,Gambold Liesl²,Hanson Natasha³,Levy Adrian⁴

Affiliation:

1. School of Public Administration; Dalhousie University; Halifax Nova Scotia Canada

2. Department of Sociology and Social Anthropology; Dalhousie University; Halifax Nova Scotia Canada

3. Saint John Regional Hospital; Saint John New Brunswick Canada

4. Department of Community Health and Epidemiology; Dalhousie University; Halifax Nova Scotia Canada

Publisher

Wiley

Subject

Health Policy

Reference57 articles.

1. National survey of physicians to determine the effect of unconditional incentives on response rates of physician postal surveys;Abdulaziz;BMJ Open.,2015

2. Drug formulary decision-making in two regional health authorities in British Columbia, Canada;Armstrong;Health Policy,2010

3. A synthesis of drug reimbursement decision-making processes in organization for economic cooperation and development countries;Barnieh;Value in Health,2014

4. Bias in published cost effectiveness studies: systematic review;Bell;BMJ,2006

5. Continental divide? The attitudes of US and Canadian oncologists on the cost, cost-effectiveness, and health policies associated with new cancer drugs;Berry;Journal of Clinical Oncology,2010

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Uncertainty tolerance among experts involved in drug reimbursement recommendations: Qualitative evidence from HTA committees in Canada and Poland;Health Policy;2021-03

2. The most important facilitators and barriers to the use of Health Technology Assessment in Canada: a best–worst scaling approach;Journal of Medical Economics;2021-01-01

3. Threats to the value of Health Technology Assessment: Qualitative evidence from Canada and Poland;Health Policy;2019-02

4. Drug attributes associated with the selection of drugs for reimbursement: a pilot stated preferences experiment with Canadian stakeholders;Expert Review of Pharmacoeconomics & Outcomes Research;2018-09-13

5. “There isalwaysa better way”: Managing uncertainty in decision making about new cancer drugs in Canada;The International Journal of Health Planning and Management;2018-02-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3